164 related articles for article (PubMed ID: 18061947)
21. A limited antibody panel can distinguish B-precursor acute lymphoblastic leukemia from normal B precursors with four color flow cytometry: implications for residual disease detection.
Weir EG; Cowan K; LeBeau P; Borowitz MJ
Leukemia; 1999 Apr; 13(4):558-67. PubMed ID: 10214862
[TBL] [Abstract][Full Text] [Related]
22. Immunophenotypic diagnosis of acute leukemia by using decision tree induction.
Cualing H; Kothari R; Balachander T
Lab Invest; 1999 Feb; 79(2):205-12. PubMed ID: 10068208
[TBL] [Abstract][Full Text] [Related]
23. [Classification of AML by morphologic, immunologic and cytogenetic criteria. Review with reference to subtypes in the AML-BFM-87 study].
Creutzig U; Ritter J; Ludwig WD; Harbott J; Löffler H; Schellong G
Klin Padiatr; 1993; 205(4):272-80. PubMed ID: 8377447
[TBL] [Abstract][Full Text] [Related]
24. Flow cytometric chemosensitivity analysis of blasts from patients with acute myeloblastic leukemia and myelodysplastic syndromes: the use of 7AAD with antibodies to CD45 or CD34.
Pallis M; Syan J; Russell NH
Cytometry; 1999 Dec; 37(4):308-13. PubMed ID: 10547616
[TBL] [Abstract][Full Text] [Related]
25. Differential chromatin structure-dependent binding of 7-aminoactinomycin D in normal and malignant bone marrow hematopoietic cells.
Stokke T; Holte H; Smeland EB; Lie SO; Steen HB
Cancer Res; 1992 Sep; 52(18):5007-12. PubMed ID: 1516056
[TBL] [Abstract][Full Text] [Related]
26. The definition of remission in acute leukemia with immunologic techniques.
Campana D; Coustan-Smith E; Behm FG
Bone Marrow Transplant; 1991 Dec; 8(6):429-37. PubMed ID: 1790423
[TBL] [Abstract][Full Text] [Related]
27. Leukemia-associated changes identified by quantitative flow cytometry: I. CD10 expression.
Lavabre-Bertrand T; Janossy G; Ivory K; Peters R; Secker-Walker L; Porwit-MacDonald A
Cytometry; 1994 Dec; 18(4):209-17. PubMed ID: 7895527
[TBL] [Abstract][Full Text] [Related]
28. Flow cytometric analysis of mast cells from normal and pathological human bone marrow samples: identification and enumeration.
Orfao A; Escribano L; Villarrubia J; Velasco JL; Cerveró C; Ciudad J; Navarro JL; San Miguel JF
Am J Pathol; 1996 Nov; 149(5):1493-9. PubMed ID: 8909239
[TBL] [Abstract][Full Text] [Related]
29. Detection of minimal disease in acute leukemia using flow cytometry: studies in a rat model for human acute leukemia.
Martens AC; Hagenbeek A
Cytometry; 1985 Jul; 6(4):342-7. PubMed ID: 3860369
[TBL] [Abstract][Full Text] [Related]
30. Detection of terminal transferase in acute myeloid leukemia by flow cytometry.
Paietta E; Meenan B; Heavey C; Thomas D
Cytometry; 1994 Jul; 16(3):256-61. PubMed ID: 7924695
[TBL] [Abstract][Full Text] [Related]
31. Classification and regression trees for bone marrow immunophenotyping.
Beckman RJ; Salzman GC; Stewart CC
Cytometry; 1995 Jul; 20(3):210-7. PubMed ID: 7587706
[TBL] [Abstract][Full Text] [Related]
32. Pattern of nucleolar organizer regions in human leukemic cells.
Grotto HZ; Metze K; Lorand-Metze I
Anal Cell Pathol; 1993 Jul; 5(4):203-12. PubMed ID: 8363982
[TBL] [Abstract][Full Text] [Related]
33. Immunophenotyping of acute leukemia by flow cytometric analysis. Use of CD45 and right-angle light scatter to gate on leukemic blasts in three-color analysis.
Borowitz MJ; Guenther KL; Shults KE; Stelzer GT
Am J Clin Pathol; 1993 Nov; 100(5):534-40. PubMed ID: 8249893
[TBL] [Abstract][Full Text] [Related]
34. Detection of residual leukemia with immunologic methods: technical developments and clinical implications.
Campana D; Freitas RO; Coustan-Smith E
Leuk Lymphoma; 1994; 13 Suppl 1():31-4. PubMed ID: 8075576
[TBL] [Abstract][Full Text] [Related]
35. Characterization of hematologic malignancies by flow cytometry.
Barlogie B; Latreille J; Freireich EJ; Fu CT; Mellard D; Meistrich M; Andreeff M
Blood Cells; 1980; 6(4):719-44. PubMed ID: 7008871
[TBL] [Abstract][Full Text] [Related]
36. Flow cytometry CD45 gating for immunophenotyping of acute myeloid leukemia.
Lacombe F; Durrieu F; Briais A; Dumain P; Belloc F; Bascans E; Reiffers J; Boisseau MR; Bernard P
Leukemia; 1997 Nov; 11(11):1878-86. PubMed ID: 9369421
[TBL] [Abstract][Full Text] [Related]
37. Detection of residual aneuploid leukemic cells by "continuous gating".
Kleine HD; Zech I; Nowak R; Oelschlägel U; Kundt G; Freund M
Cytometry; 1999 May; 36(1):71-6. PubMed ID: 10331629
[TBL] [Abstract][Full Text] [Related]
38. Assessment of the value of immunohistochemistry in the subtyping of acute leukemia on routinely processed bone marrow biopsy specimens with particular reference to macrophage-associated antibodies.
Horny HP; Wehrmann M; Steinke B; Kaiserling E
Hum Pathol; 1994 Aug; 25(8):810-4. PubMed ID: 8056422
[TBL] [Abstract][Full Text] [Related]
39. Detection of residual disease in pediatric B-cell precursor acute lymphoblastic leukemia by comparative phenotype mapping: a study of five cases controlled by genetic methods.
Dworzak MN; Stolz F; Fröschl G; Printz D; Henn T; Fischer S; Fleischer C; Haas OA; Fritsch G; Gadner H; Panzer-Grümayer ER
Exp Hematol; 1999 Apr; 27(4):673-81. PubMed ID: 10210325
[TBL] [Abstract][Full Text] [Related]
40. Impact of immunophenotyping on management of acute leukemias.
Béné MC; Bernier M; Castoldi G; Faure GC; Knapp W; Ludwig WD; Matutes E; Orfao A; van't Veer M
Haematologica; 1999 Nov; 84(11):1024-34. PubMed ID: 10553164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
